Ascendis Pharma, IncPalo Alto, California, United States
Disclosure information not submitted.
SUN-769 - Global Prevalence Estimates for Post-Surgical and Non-Surgical Chronic Hypoparathyroidism (Hypopt): A Systematic Literature Review and Meta-Analysis
Sunday, June 14, 20269:00 AM - 4:00 PM CT
SUN-770 - Palopegteriparatide Enhances Work Functioning and Productivity in Employed Adults with Chronic Hypoparathyroidism: 156-Week Results from the Pathway Trial
.jpg)
.jpg)